|
1
|
Buscà R and Ballotti R: Cyclic AMP a key
messenger in the regulation of skin pigmentation. Pigment Cell Res.
13:60–69. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Costin GE and Hearing VJ: Human skin
pigmentation: melanocytes modulate skin color in response to
stress. FASEB J. 21:976–994. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yamaguchi Y, Brenner M and Hearing VJ: The
regulation of skin pigmentation. J Biol Chem. 282:27557–27561.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kubo I, Kinst-Hori I, Chaudhuri SK, Kubo
Y, Sánchez Y and Ogura T: Flavonols from Heterotheca inuloides:
tyrosinase inhibitory activity and structural criteria. Bioorg Med
Chem. 8:1749–1755. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cho JC, Rho HS, Baek HS, et al:
Depigmenting activity of new kojic acid derivative obtained as a
side product in the synthesis of cinnamate of kojic acid. Bioorg
Med Chem Lett. 22:2004–2007. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ahn SM, Rho HS, Baek HS, et al: Inhibitory
activity of novel kojic acid derivative containing trolox moiety on
melanogenesis. Bioorg Med Chem Lett. 21:7466–7469. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cabanes J, Chazarra S and Garcia-Carmona
F: Kojic acid, a cosmetic skin whitening agent, is a slow-binding
inhibitor of catecholase activity of tyrosinase. J Pharm Pharmacol.
46:982–985. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Maeda K and Fukuda M: Arbutin: mechanism
of its depigmenting action in human melanocyte culture. J Pharmacol
Exp Ther. 276:765–769. 1996.PubMed/NCBI
|
|
9
|
Parvez S, Kang M, Chung HS, et al: Survey
and mechanism of skin depigmenting and lightening agents. Phytother
Res. 20:921–934. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakajima M, Shinoda I, Fukuwatari Y and
Hayasawa H: Arbutin increases the pigmentation of cultured human
melanocytes through mechanisms other than the induction of
tyrosinase activity. Pigment Cell Res. 11:12–17. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei CI, Huang TS, Fernando SY and Chung
KT: Mutagenicity studies of kojic acid. Toxicol Lett. 59:213–220.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Giroir LE, Huff WE, Kubena LE, et al:
Toxic effects of kojic acid in the diet of male broilers. Poult
Sci. 70:499–503. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Parshad R, Sanford KK, Price FM, et al:
Protective action of plant polyphenols on radiation-induced
chromatid breaks in cultured human cells. Anticancer Res.
18:3263–3266. 1998.PubMed/NCBI
|
|
14
|
Tu CX, Lin M, Lu SS, Qi XY, Zhang RX and
Zhang YY: Curcumin inhibits melanogenesis in human melanocytes.
Phytother Res. 26:174–179. 2012. View
Article : Google Scholar
|
|
15
|
al-Sereiti MR, Abu-Amer KM and Sen P:
Pharmacology of rosemary (Rosmarinus officinalis Linn) and its
therapeutic potentials. Indian J Exp Biol. 37:124–130. 1999.
|
|
16
|
Stermitz FR, Lorenz P, Tawara JN, Zenewicz
LA and Lewis K: Synergy in a medicinal plant: antimicrobial action
of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump
inhibitor. Proc Natl Acad Sci USA. 97:1433–1437. 2000. View Article : Google Scholar
|
|
17
|
Kuo CL, Chi CW and Liu TY: The
anti-inflammatory potential of berberine in vitro and in vivo.
Cancer Lett. 203:127–137. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fukuda K, Hibiya Y, Mutoh M, Koshiji M,
Akao S and Fujiwara H: Inhibition by berberine of cyclooxygenase-2
transcriptional activity in human colon cancer cells. J
Ethnopharmacol. 66:227–233. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kong W, Wei J, Abidi P, et al: Berberine
is a novel cholesterol-lowering drug working through a unique
mechanism distinct from statins. Nat Med. 10:1344–1351. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang J, Yin J, Gao H, Xu L, Wang Y and Li
M: Berberine improves insulin sensitivity by inhibiting fat store
and adjusting adipokines profile in human preadipocytes and
metabolic syndrome patients. Evid Based Complement Alternat Med.
2012:3638452012.PubMed/NCBI
|
|
21
|
Chen Y, Wang Y, Zhang J, Sun C and Lopez
A: Berberine improves glucose homeostasis in streptozotocin-induced
diabetic rats in association with multiple factors of insulin
resistance. ISRN Endocrinol. 2011:5193712011. View Article : Google Scholar
|
|
22
|
Hamsa TP and Kuttan G: Antiangiogenic
activity of berberine is mediated through the downregulation of
hypoxia-inducible factor-1, VEGF, and proinflammatory mediators.
Drug Chem Toxicol. 35:57–70. 2012. View Article : Google Scholar
|
|
23
|
Santini E, Valjent E, Usiello A, et al:
Critical involvement of cAMP/DARPP-32 and extracellular
signal-regulated protein kinase signaling in L-DOPA-induced
dyskinesia. J Neurosci. 27:6995–7005. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang JL, Chan RC, Cheng HH, et al: Short
waves-induced enhancement of proliferation of human chondrocytes:
involvement of extracellular signal-regulated map-kinase (erk).
Clin Exp Pharmacol Physiol. 34:581–585. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yoon HS, Lee SR, Ko HC, et al: Involvement
of extracellular signal-regulated kinase in nobiletin-induced
melanogenesis in murine B16/F10 melanoma cells. Biosci Biotechnol
Biochem. 71:1781–1784. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li H and Min YS: Inhibition of
melanogenesis by Xanthium strumarium L. Biosci Biotechnol Biochem.
76:767–771. 2012. View Article : Google Scholar : PubMed/NCBI
|
